Results 181 to 190 of about 153,973 (298)

Association of HPV Status With Quality of Life After Transoral Robotic Surgery for T1–T2 Oropharyngeal Carcinoma

Head &Neck, EarlyView.
ABSTRACT Background In T1–T2 oropharyngeal squamous cell carcinoma (OPSCC), factors associated with patient‐reported quality of life after transoral robotic surgery (TORS) are poorly defined. Methods Retrospective cohort of 59 patients with T1–T2 OPSCC treated with TORS.
Paolo Tesauro, Michel Khalaf, Ingrid Breuskin, Giuseppe Mercante, Stéphane Temam, Philippe Gorphe   +5 more
wiley   +1 more source

Tumor thickness as a novel risk factor for lymph node metastasis by superficial squamous cell carcinoma of head and neck. [PDF]

Cancer Sci
Fujii S, Katada C, Watanabe H, Shimoda T, Ochiai A, Yokoyama T, Sakamoto Y, Kano K, Ichinoe M, Nemoto T, Fujita M, Tateishi Y, Sugiura H, Mikami T, Yano T, Kato T, Muto M, Hayashi R.   +17 more
europepmc   +1 more source

The Association Between Muscle Health and Quality of Life in Patients With Head and Neck Cancer: A Systematic Review

Head &Neck, EarlyView.
ABSTRACT Background Patients with head and neck cancer (HNC) are at risk of impaired muscle health due to metabolic disturbances, reduced nutritional intake, and treatment‐related toxicities. Because muscle health supports physical capacity and independence, its decline may affect quality of life (QoL).
Tycho Zuijlen, Lina van Lint, Christian Preissner, Remco de Bree, Caroline M. Speksnijder   +4 more
wiley   +1 more source

Nimotuzumab combined with radiotherapy+/- chemotherapy for definitive treatment of locally advanced squamous cell carcinoma of head and neck: a metanalysis of randomized controlled trials. [PDF]

Front Oncol
Guan M, Zhang D, Zhao Y, Mao M, Shen K, Wang X, Bi C.   +6 more
europepmc   +1 more source

Mir-3928 in Saliva as Potential Biomarker for Head and Neck Squamous Cell Carcinoma

, 2019
Objectives: To determine whether salivary miR-3928 can be used for early head and neck cancer diagnostic purpose. Methods: The expression level of human salivary miR-3928 was investigated in 230 supernatant saliva samples.
Good, David, Nair, Raj, Fadhil, Rushdi, Wei, Ming, Nikolarakos, Dimitrios   +4 more
core  

Gene signatures characterizing driver mutations in lung squamous carcinoma are predictive of the progression of pre‐cancer lesions

International Journal of Cancer, EarlyView.
What's New? Lung squamous cell carcinoma (LUSC) is more aggressive than lung adenocarcinoma, and is most often diagnosed at an advanced stage. Here, the authors evaluated gene expression data from LUSC tumors and came up with gene signatures for 34 genetic abnormalities whose expression changes throughout different precancerous stages. Several of these
Yupei Lin, Venugopalareddy Mekala, Jianrong Li, Xiang Wang, Muhammad Aminu, Jia Wu, Jianjun Zhang, Robert Taylor Ripley, Christopher I. Amos, Chao Cheng   +9 more
wiley   +1 more source

The Silent Masquerade: Hypopharyngeal Squamous Cell Carcinoma Presenting as Recurrent Deep Neck Abscess in a Young Adult: A Case Report and Literature Review

International Journal of Medical Students
Background: Deep neck space infections are common otolaryngologic emergencies that usually have a bacterial origin. However, a rare subset of head and neck squamous cell carcinomas (HNSCC) can present as cystic, necrotic masses that clinically mimic ...
Muhammad Suliman Sajid, Sheeza Afzal, Shayan Asmat, Muhammad Haris, Ameena Nasir, Muhammad Amir Sohail, Muhammad Osama Afzal, Uzair Asad   +7 more
doaj  

Pretreatment EBV‐DNA/TLG‐Based Risk Stratification Is Associated With Survival Outcomes in Nonmetastatic Nasopharyngeal Carcinoma: An Exploratory Study

International Journal of Cancer, EarlyView.
ABSTRACT Whether combining pretreatment plasma Epstein–Barr virus DNA (EBV‐DNA) with 18F‐FDG PET/CT‐derived total lesion glycolysis (TLG) improves prognostic stratification in nonmetastatic nasopharyngeal carcinoma (NPC) is unclear, particularly in nonendemic populations.
Mehmet Çağrı Duymaz, Ece Özkaya Duymaz, Nazlı Ünsal, Recep Bekiş, Büşra Tozduman, Özgür Appak, Ayşe Demiral, Oğuz Çetinayak   +7 more
wiley   +1 more source

Activity of Low Dose Nivolumab in Patients With Advanced Squamous Cell Carcinomas and Other Cancers

International Journal of Cancer, EarlyView.
ABSTRACT Immune checkpoint inhibitors such as anti–PD‐1 antibodies are essential in cancer therapy. Emerging data suggest that lower doses may be effective and more economical, though further evidence is needed. We conducted a retrospective study at Centre Léon Bérard to assess the efficacy and safety of low‐dose nivolumab (20 mg every 3 weeks) in ...
Thibault Gauduchon, Jerome Fayette, Mona Amini‐Adle, Eve‐Marie Neidhart‐Berard, Mehdi Brahmi, Armelle Dufresne, Margaux Dupont, Clelia Coutzac, Axel de Bernardi, Philippe Toussaint, Benoite Mery, Laura Crumbach, Isabelle Ray‐Coquard, Aurélie Dutour, Marie Castets, Jean‐Yves Blay, Pierre Etienne Heudel   +16 more
wiley   +1 more source

Walking one hour per day and the derived neutrophil-to-lymphocyte ratio are associated with outcome in palliative second-line immunotherapy for patients with recurrent and/or metastatic squamous cell carcinoma of head and neck. [PDF]

Braz J Otorhinolaryngol
Caballero-Borrego M, Piedra A, Gallego Ó, López-Pousa A, Castillo P, Navarrete P, Prat A, Grau JJ.   +7 more
europepmc   +1 more source